Ajouter à une liste

Instrument Inactif

Connexions NOVARTIS London S.E.

Actions

0HKE

CH0012005267

Produits pharmaceutiques

Cours en clôture London S.E. Autres places de cotation
- ^GBX	-

13/07	Novartis : Santé Canada approuve le Vanrafia pour le traitement de la néphropathie à IgA	MT
13/07	Le Canada homologue Vanrafia de Novartis	AW

46

Sociétés cotées

50

Entreprise privées

482

Insiders

Graphique Relationnel des Sociétés Cotées liées: NOVARTIS

Relations Actives

Relations Passées

Sociétés Cotées liées: NOVARTIS

Liz Doherty Doherty

STRYKER CORPORATION

Giovanni Caforio

WATERS CORPORATION

Flemming Ørnskov

STMICROELECTRONICS N.V.

Ana de Pro Gonzalo

METTLER-TOLEDO INTERNATIONAL, INC.

Marie-France Tschudin

PHIBRO ANIMAL HEALTH CORPORATION

Judith Weinstein

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

MONDELEZ INTERNATIONAL, INC.

Dirk van de Put

OBERSTDORFER BERGBAHN AG

MILESTONE PHARMACEUTICALS INC.

AURA BIOSCIENCES, INC.

Antony Mattessich

Nicoleta Baumgärtner

Liz Doherty Doherty

SCHINDLER HOLDING AG

MOBICO GROUP PLC

Ana de Pro Gonzalo

GEORG FISCHER AG

SWISS PRIME SITE AG

BACHEM HOLDING AG

Bridgette Heller

SANTHERA PHARMACEUTICALS HOLDING AG

DKSH HOLDING AG

Bridgette Heller

MOLECULAR PARTNERS AG

Michael Pitzner

Susanne Antonie Schaffert

MEDARTIS HOLDING AG

BICYCLE THERAPEUTICS PLC

Alessandro Riva

Charles Swanton

ADC THERAPEUTICS SA

CANDEL THERAPEUTICS, INC.

Nicoletta Loggia

Seshu Tyagarajan

AURINIA PHARMACEUTICALS INC.

Charles Sawyers

Alessandro Riva

Giancarlo Benelli

ABSCI CORPORATION

Frans van Houten

JOHNSON CONTROLS INTERNATIONAL PLC

Shannon Klinger

AGOMAB THERAPEUTICS NV

Angelika Jahreis

TANGO THERAPEUTICS, INC.

NRX PHARMACEUTICALS, INC.

RALLYBIO CORPORATION

OCULIS HOLDING AG

SANDOZ GROUP AG

Karen Hübscher

Elizabeth Theophille

Relations Actives

Relations Passées

Graphique Relationnel des Sociétés Privées liées: NOVARTIS

Relations Actives

Relations Passées

Entreprise Privées liées: NOVARTIS

Novartis International AG

Pharmaceuticals: Major

Hans Jörg Reinhardt

Shannon Klinger

Harry Werner Kirsch

Vasant Narasimhan

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Deborah Dunsire

Flemming Ørnskov

Meenu Chhabra Karson

Royston Glasspool

Serica Technologies, Inc.

Pharmaceuticals: Major

abrdn Healthcare Investors

Investment Trusts/Mutual Funds

abrdn Life Sciences Investors

Investment Trusts/Mutual Funds

abrdn Healthcare Opportunities Fund

Investment Trusts/Mutual Funds

abrdn World Healthcare Fund

Investment Trusts/Mutual Funds

STADA Arzneimittel AG

Pharmaceuticals: Generic

Miguel Fernandez

Novo Holdings A/S (Denmark)

Investment Managers

Susanne Antonie Schaffert

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Jonathan Symonds

The General Hospital Corp.

Hospital/Nursing Management

Mason W. Freeman

Atlas Venture Advisors, Inc.

Investment Managers

Northwestern University

Other Consumer Services

Bridgette Heller

Elizabeth McNally

University of St. Gallen

Other Consumer Services

Ruth Metzler-Arnold

American Bar Association

Miscellaneous Commercial Services

Shannon Klinger

Diane E. Sugrue

Novartis Pharmaceuticals Corp.

Pharmaceuticals: Major

Hans Jörg Reinhardt

Thomas N. Kendris

Vasant Narasimhan

University of Basel

Other Consumer Services

Jutta Monika Heim

John Martin Manser

Verena A. Briner

Speedel Pharma AG

Pharmaceuticals: Major

National Academy of Sciences

Miscellaneous Commercial Services

William J. Rutter

Charles Sawyers

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Ann Marie Fudge

William J. Rutter

Charles Sawyers

National Academy of Medicine (United States)

Miscellaneous Commercial Services

Charles Sawyers

Vasant Narasimhan

The District of Columbia Bar

Miscellaneous Commercial Services

Shannon Klinger

Theresa Maria Stevens

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Giovanni Caforio

Massachusetts Biotechnology Council

Miscellaneous Commercial Services

Novartis Institutes for Biomedical Research, Inc.

Miscellaneous Commercial Services

Hans Jörg Reinhardt

Harry Werner Kirsch

Novartis Pharma AG

Pharmaceuticals: Major

Hans Jörg Reinhardt

Vasant Narasimhan

Shreeram Aradhye

Harvard Medical School

Other Consumer Services

Mason W. Freeman

Vasant Narasimhan

Waters Technologies Corp.

Medical Specialties

E. Merck KG

Pharmaceuticals: Major

Susanne Antonie Schaffert

IMD Scholarship Foundation

Karen Hübscher

Marie-France Tschudin

SIX Swiss Exchange AG

Investment Banks/Brokers

Andreas von Planta

Novartis Pharma KK

Pharmaceuticals: Major

Harry Werner Kirsch

Novartis Pharma BV

Hans Jörg Reinhardt

Vasant Narasimhan

Swiss Bar Association

Laurent Sigismondi

Zurich Bar Association

Daniel Hochstrasser

The Consumer Goods Forum

Miscellaneous Commercial Services

Dirk van de Put

Association of the European Self-Medication Industry

Affidea BV

Medical/Nursing Services

Stefan Mario Meister

Frans van Houten

Galderma Holding SA

Pharmaceuticals: Major

Flemming Ørnskov

Vasomune Therapeutics, Inc.

Pharmaceuticals: Other

Meenu Chhabra Karson

Fore Biotherapeutics, Inc.

Pharmaceuticals: Major

Meenu Chhabra Karson

Novartis Foundation

Miscellaneous Commercial Services

Hans Jörg Reinhardt

Andreas von Planta

Vasant Narasimhan

Aberdeen Investments LLC

Financial Conglomerates

CIBA Vision GmbH (Germany)

Electronic Components

Susanne Antonie Schaffert

ImmunOs Therapeutics AG

Biotechnology

Reinhard Ambros

Ring Therapeutics, Inc.

Pharmaceuticals: Major

Medartis AG

Anthony Durieux-Menage

Valo Health LLC

Packaged Software

Shreeram Aradhye

Abata Therapeutics, Inc.

Biotechnology

Nagesh Mahanthappa

Teres Bio, Inc.

Pharmaceuticals: Major

Relations Actives

Relations Passées

Statistiques des Connexions

Actives

Inactives

Sociétés cotées

Entreprise privées

Activités des Sociétés liées

Pharmaceuticals: Major	22
Miscellaneous Commercial Services	14
Biotechnology	14
Medical Specialties	7
Other Consumer Services	4
Investment Trusts/Mutual Funds	4
Industrial Machinery	3
Medical/Nursing Services	2
Food: Specialty/Candy	2
Investment Managers	2

Pays des Sociétés liées

Etats-Unis	42
Suisse	27
Allemagne	6
Pays-Bas	5
Belgique	4
Royaume-Uni	3
Canada	3
France	3
Japon	1
Danemark	1

Profil Société

Novartis AG figure parmi les leaders mondiaux de la conception, de la fabrication et de la commercialisation de produits pharmaceutiques. Le CA par domaine thérapeutique se répartit comme suit : - oncologie (30,9%) ; - immunologie (18,9%) ; - maladies cardio-vasculaires, rénales et métaboliques (16,4%) ; - neuroscience (11%) ; Le solde du CA (22,8%) concerne l'activité de fabrication en sous-traitance de produits pharmaceutiques. A fin 2025, Novartis AG dispose de plus de 31 sites de production dans le monde. La répartition géographique du CA est la suivante : Suisse (2,6%), Europe (28,1%), Etats-Unis (42,8%), Asie-Afrique-Australasie (19,8%), Canada et Amérique latine (6,7%).

Employés

-

Secteur

Produits pharmaceutiques

Agenda

Publication des résultats - Q2 2026

Plus d'informations sur la société

Google vous laisse choisir vos sources.

G Google

Choisissez Zonebourse

G Google

Choisissez Zonebourse